CIK: 1654337 - Address: C/o Pds Biotechnology Corporation, 303A College Road East, Princeton, NJ 08540
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret113-2-4111931011
S%wins100100330047

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/4/21 19:52
6/3/21
ACRSAclaris Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAli-Jackson KamilPAOGCS-20821.960-9-7122D
6/2/21 21:47
6/1/21
ACRSAclaris Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAli-Jackson KamilPAOGCS.dm-99722.100-45-26132D
5/7/21 18:28
5/6/21
ACRSAclaris Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAli-Jackson KamilPAOGCS.dm-47923.450-20-12144D
5/5/21 20:04
5/3/21
ACRSAclaris Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAli-Jackson KamilPAOGCS.dm-1,08424.080-45-24144D
6/12/18 18:42
6/11/18
ACRSAclaris Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAli-Jackson KamilPAOGCS.m-10020.000-5-678D
5/21/18 16:06
5/18/18
ACRSAclaris Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAli-Jackson KamilPAOGCS-20020.000-10-1183D
10/28/16 16:10
10/26/16
ACRSAclaris Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAli-Jackson KamilPAOGCS.d-8521.832-4-576D50169-12-13-6-40-3312232
9/28/16 18:10
9/28/16
ACRSAclaris Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAli-Jackson KamilPAOGCS.d-4524.663-2-276D6339261130-1-2-13920
8/29/16 16:15
8/26/16
ACRSAclaris Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAli-Jackson KamilPAOGCS-7620.351-4-1620D16761460-5-6142642

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact